American Thrombosis and Hemostasis Network

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, American Thrombosis and Hemostasis Network sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).

8 total trials 3 currently recruiting 4 completed later-stage tilt upper quartile by trial count

American Thrombosis and Hemostasis Network: 8 sponsored US clinical trials, 3 recruiting.

American Thrombosis and Hemostasis Network sponsors 8 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 4 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Von Willebrand Diseases, with 2 trials.

Upper-quartile sponsor footprint

American Thrombosis and Hemostasis Network sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

8 total, page 1 of 1

RECRUITING

ATHNdataset Registry

NCT06820515
RECRUITING Phase 4

SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

NCT04647227
RECRUITING

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

NCT04398628
ACTIVE NOT RECRUITING

ATHN 9: Severe VWD Natural History Study

NCT03853486
COMPLETED

ATHN 11: Liver Transplantation Outcomes Study

NCT04055051
COMPLETED

ATHN 7: Hemophilia Natural History Study

NCT03619863
COMPLETED

ATHN 8: Previously Untreated Patients (PUPs) Matter Study

NCT03818529
COMPLETED

ATHN 2: Factor Switching Study

NCT02546622

Phase Distribution

PhaseTrial count
Phase 4 1

Therapeutic Areas

Von Willebrand Diseases 2
Hemophilia B With Inhibitor 1
Hemophilia A With Inhibitor 1
Factor IX Deficiency 1
Platelet Disorder 1
Rare Bleeding Disorder 1
Thrombophilia 1
Thrombosis 1
Hemophilia 1
Connective Tissue Disorder 1

Where American Thrombosis and Hemostasis Network enrollment is open (later-stage tilt)

3 recruiting of 8 indexed (38% open); 4 completed (50%).

Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).

Top condition: Von Willebrand Diseases (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

American Thrombosis and Hemostasis Network: open-pipeline peers nationwide

Peers matched on 8 registered trials and 38% open enrollment, not the therapeutic-area sidebar.

American Thrombosis and Hemostasis Network sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 8.088.1 0%10%20%30%40% Total trials Recruiting share American Thrombosis and Hemostasis NetworkAB ScienceAbbott Point of CareAbeona TherapeuticsAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)AskBioAthletic Greens InternationalBanner HealthCND Life Sciences
American Thrombosis and Hemostasis Network sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

American Thrombosis and Hemostasis Network sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 8 trials (± recruiting share)

Sponsors near 38% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this American Thrombosis and Hemostasis Network page

8 registered trials is a research-attention snapshot, not an endorsement of American Thrombosis and Hemostasis Network or any single study.

  • 3 of American Thrombosis and Hemostasis Network's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Von Willebrand Diseases is the condition American Thrombosis and Hemostasis Network studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Von Willebrand Diseases trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. American Thrombosis and Hemostasis Network pipeline card: 8 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.